References and Notes
1
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
41:
2596
2
Tornoe CW.
Christensen C.
Meldal M.
J. Org. Chem.
2002,
67:
3057
3
Wu P.
Fokin VV.
Aldrichimica Acta
2007,
40:
7
4
Bock VD.
Hiemstra H.
van Maarseveen JH.
Eur. J. Org. Chem.
2005,
51
5
Kolb HC.
Finn MG.
Sharpless KB.
Angew. Chem. Int. Ed.
2001,
40:
2004
6
Speers AE.
Cravatt BF.
Chem. Biol.
2004,
11:
535
7
Kosiova I.
Kovackova S.
Kois P.
Tetrahedron
2007,
63:
312
8
Gierlich J.
Burley GA.
Gramlich PME.
Hammond DM.
Carell T.
Org. Lett.
2006,
8:
3639
9
Bouillon C.
Meyer A.
Vidal S.
Jochum A.
Chevolot Y.
Cloarec JP.
Praly JP.
Vasseur JJ.
Morvan F.
J. Org. Chem.
2006,
71:
4700
10
Perez-Balderas F.
Ortega-Munoz M.
Morales-Sanfrutos J.
Hernandez-Mateo F.
Calvo-Flores FG.
Calvo-Asin JA.
Isac-Garcia J.
Santoyo-Gonzalez F.
Org. Lett.
2003,
5:
1951
11
Kuijpers BHM.
Groothuys S.
Keereweer AR.
Quaedflieg P.
Blaauw RH.
van Delft FL.
Rutjes F.
Org. Lett.
2004,
6:
3123
12
Odlo K.
Hoydahl EA.
Hansen TV.
Tetrahedron Lett.
2007,
48:
2097
13
Chittaboina S.
Xie F.
Wang Q.
Tetrahedron Lett.
2005,
46:
2331
14
Kacprzak K.
Synlett
2005,
943
15
Feldman AK.
Colasson B.
Fokin VV.
Org. Lett.
2004,
6:
3897
16
Andersen J.
Bolvig S.
Liang XF.
Synlett
2005,
2941
17
Barral K.
Moorhouse AD.
Moses JE.
Org. Lett.
2007,
9:
1809
18
Beckmann HSG.
Wittmann V.
Org. Lett.
2007,
9:
1
19
Nepogodiev SA.
Dedola S.
Marmuse L.
de Oliveira MT.
Field RA.
Carbohydr. Res.
2007,
342:
529
20
Seela F.
Sirivolu VR.
Helv. Chim. Acta
2007,
90:
535
21
Zheng SL.
Reid S.
Lin N.
Wang BH.
Tetrahedron Lett.
2006,
47:
2331
22 A quick search in the Aldrich catalogue (sigma-aldrich.com) found 269 commercial alkynes vs. 870 aldehydes.
23
Ohira S.
Synth. Commun.
1989,
19:
561
24
Muller S.
Liepold B.
Roth GJ.
Bestmann HJ.
Synlett
1996,
521
25
General Experimental Procedure: The aldehyde (2 mmol), 2-oxopropyldiazodimethyl phosphonate (4 mmol) and K2CO3 (6 mmol) were suspended in MeOH-THF (1:1; 4 mL) under an argon atmosphere. The reaction mixture was stirred at r.t. until TLC showed the reaction to be complete (2-24 h, in some cases another 0.5 equiv of the reagent was needed to reach completion). When the starting aldehyde was completely converted into the intermediate alkyne, CuI (0.4 mmol) and the azide (2 mmol) were added, and the reaction mixture was stirred at r.t. The progress of the reaction was followed by TLC (2-12 h). The solvents were removed in vacuo and the residue was dissolved in EtOAc (20 mL) and H2O (20 mL). The aqueous layer was washed with EtOAc (2 × 20 mL). The organic phase was washed with a sat. solution of NH4Cl (20 mL), brine (20 mL) and dried over anhyd Na2SO4. The solvent was removed in vacuo and the crude product was further purified by column chromatography (n-hexane-EtOAc).
Characterization Data for Selected Compounds:
1-{2′-Deoxy-4′-[1-(pyren-1-ylmethyl)-1,2,3-triazol-4-yl]-3′-
O
-
tert
-butyldimethylsilyl-β-d
-erythrofurano-syl}thymine (Table 1, entry 6): yield: 73%; mp 125-126 °C; R
f
0.53 (n-hexane-EtOAc, 5:5). 1H NMR (300 MHz, CDCl3): δ = 0.03 (s, 3 H), 0.13 (s, 3 H), 0.75 (s, 9 H), 1.69 (s, 3 H), 2.20-2.29 (m, 1 H), 2.48-2.57 (m, 1 H), 4.66-4.68 (m, 1 H), 4.79 (d, J = 2.6 Hz, 1 H), 6.29 (s, 2 H), 6.44 (t, J = 5.9 Hz, 1 H), 7.31 (s, 1 H), 7.64 (s, 1 H), 7.99-8.16 (m, 9 H).13C NMR (75 MHz, CDCl3): δ = 4.8, 4.9, 12.4, 25.6, 40.4, 52.5, 75.8, 80.8, 85.7, 111.1, 121.7, 122.4, 124.5, 125.0, 125.2, 125.9, 126.1, 126.2, 126.5, 127.2, 127.8, 128.5, 129.3, 129.4, 130.5, 131.2, 132.3, 136.3, 140.0, 150.2, 163.4. MS (ESI+): m/z (%) = 608 (100) [M + H]+. HRMS (FAB+, NBA): m/z calcd for C34H38N5O4Si (M + H+): 608.2693; found: 608.2712.
(2
S
,3
R
)-
tert
-Butyl-2-(benzyloxycarbonylamino)-3-[4-(pyren-1-yl)-1,2,3-triazol-1-yl]butanoate (Table 1, entry 10): yield: 75%; mp 81-83 °C; [α]20 +12° (c = 1, CHCl3); R
f
0.10 (n-hexane-EtOAc, 8:2). 1H NMR (300 MHz, CDCl3): δ = 1.49 (s, 9 H), 1.83 (d, J = 6.8 Hz, 3 H), 4.85-4.89 (dd, J = 4.8, 8.5 Hz, 1 H), 5.11 (m, 1 H), 5.17 (s, 2 H), 5.90 (d, J = 8.3 Hz, 1 H), 7.18-7.31 (m, 3 H), 7.76-7.78 (m, 2 H), 8.00-8.14 (m, 9 H), 8.67 (d, J = 9.3 Hz, 1 H).13C NMR (75 MHz, CDCl3): δ = 21.4, 27.9, 58.3, 58.8, 84.0, 122.0, 124.7, 124.8, 125.2, 125.4, 126.1, 126.3, 127.2, 127.4, 127.8, 128.1, 128.2, 128.3, 128.5, 128.6, 129.6, 130.9, 131.3, 131.4, 139.3, 143.3, 147.2, 155.9, 167.9. MS (ESI+): m/z (%) = 561 (100) [M + H]+. HRMS (ESI+): m/z calcd for C34H33N4O4 (M + H+): 561.2502; found: 561.2480.
1-{2′-Deoxy-4′-[1-(2′,3′,4′,6′-tetra-
O
-benzyl-β-d
-gluco-pyranosyl)[1,2,3]triazol-4-yl]-3′-
O
-
tert
-butyldimethyl-silyl-β-d
-erythrofuranosyl}thymine (Table 1, entry 11): yield: 80%; mp 80-83 °C; R
f
0.51 (n-hexane-EtOAc, 5:5). 1H NMR (300 MHz, CDCl3): δ = 0.00 (s, 3 H), 0.05 (s, 3 H), 0.88 (s, 9 H), 1.84 (s, 3 H), 2.34-2.63 (m, 2 H), 3.78-3.89 (m, 2 H), 4.05-4.18 (m, 2 H), 4.47-4.96 (m, 10 H), 5.61 (d, J = 9.0 Hz, 1 H), 6.53 (t, J = 6.80 Hz, 1 H), 6.92-6.96 (m, 2 H), 7.16-7.33 (m, 20 H), 7.64 (s, 1 H), 7.82 (s, 1 H), 9.10 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = -4.79, -4.76, 12.5, 17.9, 25.6, 40.4, 68.3, 73.6, 74.8, 75.2, 75.8, 77.2, 77.5, 78.1, 80.2, 80.9, 85.5, 85.8, 87.6, 111.2, 122.1, 127.7, 127.8, 127.9, 128.0, 128.1, 128.2, 128.4, 128.5, 136.6, 136.8, 137.6, 138.0, 146.1, 150.6, 163.9. MS (ESI+): m/z (%) = 916.3 (100) [M + H]+. HRMS (ESI+): m/z calcd for C51H62N5O9Si (M + H+): 916.4317; found: 916.4327.
3′-[4-(2′-Deoxy-3′-
O
-
tert
-butyldimethylsilyl-1′-thyminyl-β-d
-erythrofuranos-4′-yl)-1,2,3-triazol-1-yl]thymidine (Table 1, entry 13): yield: 85%; mp 139-140 °C; R
f
0.09 (CH2Cl2-EtOAc, 5:5). 1H NMR (300 MHz, CDCl3): δ = 0.06 (2 × s, 6 H), 0.87 (s, 9 H), 1.92 (s, 3 H), 1.95 (s, 3 H), 2.33-2.71 (m, 2 H), 2.94-3.09 (m, 2 H), 3.82-4.12 (m, 2 H), 4.44-4.46 (m, 1 H), 4.71-4.74 (m, 1 H), 4.97 (d, J = 3.01 Hz, 1 H), 5.43-5.49 (m, 1 H), 6.21 (t, J = 6.55 Hz, 1 H), 6.36 (t, J = 6.4 Hz, 1 H), 7.41 (s, 1 H), 7.65 (s, 1 H), 7.80 (s, 1 H), 8.61 (br s, 1 H), 8.64 (br s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 4.83, 12.4, 12.5, 14.2, 25.7, 36.5, 39.8, 59.1, 60.6, 61.2, 76.2, 81.0, 85.3, 87.5, 88.4, 111.2, 122.3, 137.6, 137.7, 146.0, 150.6, 150.8, 164.1, 164.2. MS (ESI+): m/z (%) = 618 (100) [M + H]+. HRMS (FAB+, NBA): m/z calcd for C27H39N7O8Si (M + H+): 618.2708; found: 618.2682.
26
Yang W.
Gao X.
Wang B.
Boronic Acids
Hall DG.
Wiley-VCH;
Weinheim:
2005.
Chap. 13.
27
James TD.
Boronic Acids
Hall DG.
Wiley-VCH;
Weinheim:
2005.
Chap. 12.
28
Luvino D.
Smietana M.
Vasseur JJ.
Tetrahedron Lett.
2006,
47:
9253
29
Characterization Data for Selected Compounds: 1-Benzyl-4-[3-(4,4,5,5-tetramethyl-1,3-dioxa-2-borolan-2-yl)phenyl]-1,2,3-triazole (Table 2, entry 1): yield: 30%; white solid; mp 172-173 °C; R
f
0.24 (n-hexane-EtOAc, 8:2). 1H NMR (300 MHz, CDCl3): δ = 1.22 (s, 12 H), 5.44 (s, 2 H), 7.14-7.33 (m, 5 H), 7.25 (s, 1 H), 7.59 (s, 1 H), 7.64 (m, 1 H), 7.92 (m, 1 H), 7.97 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 22.6, 52.0, 81.7, 117.4, 125.8, 126.1, 126.4, 126.5, 126.9, 127.8, 129.7, 132.3, 132.5, 146.0. MS (ESI+): m/z (%) = 362.2 (100) [M + H]+. HRMS (ESI+): m/z calcd for C21H25BN3O2 (M + H+): 362.2040; found: 362.2037.
1-(Pyren-1-ylmethyl)-4-[4-(4,4,5,5-tetramethyl-1,3-dioxa-2-borolan-2-yl)phenyl]-1,2,3-triazole (Table 2, entry 4): yield: 55%; mp 168-170 °C; R
f
0.14 (n-hexane-EtOAc, 8:2). 1H NMR (400 MHz, CDCl3): δ = 1.23 (s, 12 H), 6.21 (s, 2 H), 7.22 (d, J = 7.9 Hz, 2 H), 7.44-7.74 (m, 3 H), 7.92-8.19 (m, 8 H), 8.17 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 24.8, 55.3, 83.8, 119.9, 121.9, 124.8, 125.9, 126.0, 126.5, 127.2, 127.8, 128.4, 128.7, 129.2, 129.4, 130.6, 131.2, 132.3, 132.9, 135.2, 139.1, 143.6, 147.9. MS (ESI+): m/z (%) = 486 (100) [M + H]+. HRMS (ESI+): m/z calcd for C31H29BN3O2 (M + H+): 486.2353; found: 486.2378.